ÌÇÐÄÆƽâ°æ

Genetic testing market size worldwide 2024-2034

Annual value of the genetic testing market worldwide from 2024 to 2034 (in billion U.S. dollars)

Genetic testing market worldwide 2024, by end-use

Distribution of the genetic testing market worldwide in 2024, by end-use

Genetic test average cost used for precision medicine worldwide by region 2022-2027

Average cost of a genetic test used for precision medicine worldwide from 2022 to 2027, by region (in U.S. dollars)

Genetic test average cost used for precision medicine worldwide 2022-2027

Average cost of a genetic test used for precision medicine worldwide from 2022 to 2027 (in U.S. dollars)

Number of genetic tests used for precision medicine globally 2022-2027

Total number of genetic tests used for precision medicine worldwide from 2022 to 2027 (in millions)

Share of genetic tests used for precision medicine by world region 2022-2027

Percentage of genetic tests used for precision medicine worldwide from 2022 to 2027, by region

Share of genetic tests used for precision medicine globally 2022-2027

Percentage of genetic tests used for precision medicine worldwide from 2022 to 2027

Most talked-about DNA companies worldwide Q1 2022

Leading DNA companies worldwide between January and March 2022, by number of online impressions

23andMe revenue 2021-2024

Revenue of 23andMe from 2021 to 2024 (in million U.S. dollars)

23andMe net income 2021-2024

Net income of 23andMe from 2021 to 2024 (in million U.S. dollars)

Illumina, Inc. revenue 2021-2025

Revenue of Illumina, Inc. from 2021 to 2025 (in billion U.S. dollars)

Exact Sciences revenue 2021-2025

Revenue of Exact Sciences from 2021 to 2025 (in billion U.S. dollars)

Qiagen revenue 2012-2024

Revenue of Qiagen from 2012 to 2024 (in million U.S. dollars)

Guardant Health revenue 2021-2025

Revenue of Guardant Health from 2021 to 2025 (in million U.S. dollars)

Neogenomics revenue 2021-2025

Revenue of Neogenomics from 2021 to 2025 (in million U.S. dollars)

Fulgent Genetics revenue 2021-2025

Revenue of Fulgent Genetics from 2021 to 2025 (in million U.S. dollars)

Invitae revenue 2018-2022

Revenue of Invitae from 2018 to 2022 (in million U.S. dollars)

Willingness to know future cancer risk via genetic testing in the U.S. 2022

Distribution of willingness to know cancer risk via a genetic test in the United States in 2022, by type

Reasons for taking a genetic test in the U.S. 2022

Reasons adults took a genetic test in the United States as of 2022

Confidence in accuracy of genetic testing in the U.S. in 2022

Distribution in confidence of genetic test results in the United States in 2022

Use of genetic testing in the U.S. in 2022, by type

Share of people who have ever had a genetic test in the United States in 2022, by type

Adults taking a genetic test to share the results with relatives U.S. 2024, by gender

Share of adults who took a genetic test because they want to share the results with relatives in the United States in 2024, by gender

Concerns regarding the impact of genetic testing for cancer risk in the U.S. 2023

Share of people who were concerned the following areas would be impacted by genetic tests to determine cancer risk in the United States in 2023

Familiarity with genetic testing to determine cancer risk in the U.S. in 2023, by age

Share of people who had heard of genetic testing to determine cancer risk in the United States in 2023, by age

Awareness of DTC genetic testing companies among health professionals Europe 2022

Awareness of DTC genetic testing companies among health professionals Europe as of 2022

Attitudes towards DTC genetic testing among health professionals Europe 2022

Distribution of opinions among health professionals regarding the results of DTC genetic testing in Europe as of 2022

Belief in regulations on DTC genetic testing among health professionals Europe 2022

Share of health professionals who believed the following aspects DTC genetic testing should be regulated in Europe as of 2022

Behavior changes as a result of genetic testing in the U.S. 2022

Behavior changes as a result of genetic testing in the United States as of 2022

Taking a genetic test due to doctor recommendation U.S. 2024, by gender

Share of adults who took a genetic test because of their doctor's recommendation in the United States as of 2024, by gender

Use of genetic tests to make health decisions U.S. 2024, by gender

Share of adults who took a genetic test so that the information would affect their healthcare decisions in the United States in 2024, by gender

Use of genetic testing for cancer risk in the U.S. in 2023, by gender

Share of people who have ever had a genetic test to determine cancer risk in the United States in 2023, by gender

Use of genetic testing for cancer risk in the U.S. in 2023, by age

Share of people who have ever had a genetic test to determine cancer risk in the United States in 2023, by age

National policy/programs of noninvasive prenatal testing in Europe 2020, by country

Adoption of noninvasive prenatal testing (NIPT) in national policy and programs in Europe as of 2020, by country

Share of women receiving noninvasive prenatal testing in Europe 2020, by country

Share of pregnant women who received noninvasive prenatal testing (NIPT) in national policy and programs in Europe in 2020, by country

Noninvasive prenatal testing market size in the United States 2023-2033

Annual value of the noninvasive prenatal testing market in the United States from 2023 to 2033 (in billion U.S. dollars)

Attitudes towards the development of cell and gene therapies in the U.S. 2023

Distribution of attitudes towards the development and commercialization of cell and gene therapies in the past and near future as of 2023

Commercialization considerations regarding cell and gene therapies in the U.S. 2023

Organizations' considerations regarding commercialization of cell and gene therapies in the United States as of 2023, by organization type

Number of active trials for cell and gene therapies worldwide 2022 by trial phase

Number of active trials for cell and gene therapies in the global pipeline as of 2022, by trial phase